Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,315 | -2,494 | -826 | -171 | 513 |
| Depreciation Amortization | 659 | 2,495 | 1,889 | 1,255 | 624 |
| Accounts receivable | -332 | 936 | 992 | 1,281 | 42 |
| Accounts payable and accrued liabilities | -259 | 342 | 19 | 23 | -146 |
| Other Working Capital | -1,219 | -1,833 | -1,505 | -181 | -546 |
| Other Operating Activity | 703 | -990 | -816 | -1,194 | 152 |
| Operating Cash Flow | $-2,762 | $-1,544 | $-246 | $1,012 | $639 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -682 | -3,964 | -2,474 | -1,740 | -797 |
| Investing Cash Flow | $-682 | $-3,964 | $-2,474 | $-1,740 | $-797 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Common Stock Issued | N/A | 31 | 31 | 31 | 6 |
| Other Financing Activity | -251 | -917 | -668 | -445 | -216 |
| Financing Cash Flow | $749 | $1,114 | $1,362 | $1,586 | $1,790 |
| Beginning Cash Position | 5,792 | 10,186 | 10,186 | 10,186 | 10,186 |
| End Cash Position | 3,096 | 5,792 | 8,828 | 11,043 | 11,817 |
| Net Cash Flow | $-2,696 | $-4,394 | $-1,358 | $858 | $1,632 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,762 | -1,544 | -246 | 1,012 | 639 |
| Capital Expenditure | -682 | -3,975 | -2,485 | -1,751 | -808 |
| Free Cash Flow | -3,444 | -5,519 | -2,731 | -739 | -169 |